Hui Li
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 16
- RNA modifications and cancer 10
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 14
- Co-authors
- Hourong Cai (16 shared papers)Jie Ren (1 shared paper)Dan Sun (1 shared paper)Xiaoxia Lü (1 shared paper)Fu-Rong Zhang (1 shared paper)Timothy S. Blackwell (5 shared papers)Zhisheng Liu (1 shared paper)Xiao Han (1 shared paper)
- Journals
- PLoS ONE (6 papers)Oncotarget (5 papers)Scientific Reports (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Frontiers in Microbiology (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Li
293 papers receiving 7.6k citations
Hui Li's Hit Papers
Peers
Comparison fields: 5 of 173
- Molecular Medicine 723
- Cancer Research 1.3k
- Endocrinology 245
- Molecular Biology 2.7k
- Immunology 720
Countries citing papers authored by Hui Li
This map shows the geographic impact of Hui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Li more than expected).
Fields of papers citing papers by Hui Li
This network shows the impact of papers produced by Hui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Li. The network helps show where Hui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel Plasmid-Mediated Colistin Resistance Gene mcr-3 in Escherichia coli Hit paper breakdown → | 2017 | 452 |
| 2 | 2020 | 429 | |
| 3 | 1996 | 286 | |
| 4 | 2019 | 207 | |
| 5 | 2012 | 183 | |
| 6 | 2018 | 151 | |
| 7 | 2020 | 137 | |
| 8 | 2013 | 131 | |
| 9 | 2014 | 130 | |
| 10 | 2019 | 117 | |
| 11 | 2012 | 100 | |
| 12 | 2020 | 96 | |
| 13 | Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. | 1994 | 81 |
| 14 | 2016 | 76 | |
| 15 | 2016 | 73 | |
| 16 | 2018 | 72 | |
| 17 | 2013 | 71 | |
| 18 | 2016 | 71 | |
| 19 | 2020 | 67 | |
| 20 | 2015 | 66 |
About Hui Li
Hui Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Oncology, having authored 306 papers that have together received 7.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (20 papers), Circular RNAs in diseases (16 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Immune Response and Inflammation (10 papers), RNA modifications and cancer (10 papers), Antibiotic Resistance in Bacteria (7 papers) and COVID-19 Clinical Research Studies (7 papers). The work is most often cited by research in Molecular Medicine (723 citations), Cancer Research (1.3k citations), Endocrinology (245 citations), Molecular Biology (2.7k citations) and Immunology (720 citations). Hui Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hourong Cai, Jie Ren, Dan Sun, Xiaoxia Lü, Fu-Rong Zhang, Timothy S. Blackwell, Zhisheng Liu, Xiao Han, Canmao Xie and Yifeng Luo. Their work appears in journals such as PLoS ONE, Oncotarget, Scientific Reports, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.